KalVista Pharmaceuticals (KALV)

[Value_Investor]

Good news today! One Big Institution just filed the New Ownership (1.7% of OS) form this afternoon --- see the link below!

http://ih.advfn.com/p.php?pid=nmona&article=72411441

With measly 13M shares Hyper Tiny float and 45.1% Huge Institution Ownerships this hidden gem could easily and quickly surge back to the most recent high $1.43 again with any good news from the company...

[Toxic Avenger]

Insiders buying and not reporting is illegal. You can bet it's not happening. Kalvista is a crap shoot and they'll need more money to bring their drug to market, even if trials go well. CBYL is only getting 20% ownership and funding their entire operation. Meanwhile, the stock is valued at less than half the remaining cash, which shows how much the market thinks of Kalvista.

[MrSparex]

I'm not sure but I think this is my 2cd post in about 6 years...
The fact this stock holds some mystery adds value (like unopened trading cards in the 90's). There's no "pumping" of this stock going on. The stats on it are very good. I spent a few minutes playing with the buy & ask the other day. If a little trader like me can change it 5 times in a row... imagine what a MM can do? Kalvista appears to have a promising drug on the way also. They've already said they're going to change the symbol in the future to correspond with their company. The fact that it has over 50% inside ownership is also promising. They could easily raise the PPS with a simple news release but they choose not to, perhaps there's still buying on their end? That makes sense considering they're holding over half the shares. CBYL appears to hold great potential for the right type of investor IMO...may be a long rough ride to the top!

[Value_Investor]

CBYL has Zero-Debt now which is a Sought-After Key fundamental for a Bio-Tech Nasdaq stock! The company has huge cash on the hand --- $36.88M which entiles $1.14 ~ $0.95 per share Huge Cash liquidation value v.s. the stock is trading at the ridiculous low price $0.4xxx currently! The BV/PPS ratio and CV/PPS ratio ever hit 3.18+ and 3.11+ respectively which are the Record high among all the Nasdaq Bio-Tech peers! Easy 200% quick huge gain from here in the coming weeks/months...

With almost the fundamental and financial balance sheet CBYL ever hit $1.43 just a few months ago! Both BV ($1.37) and CV ($1.40) are very close to that most recent high price ($1.43)!

Last Friday evening the bid was as high as $0.4802 but no any fill at all!

[Toxic Avenger]

That was about as vague and worthless a call as you could get.

[Value_Investor]

Among all the Debt-Free Bio-tech peers CBYL is the cheapest one since both the Book Value and Cash Value are over Three Times of its current ridiculous low price! Easy triple to reward the investors with over 200% huge gain from here within just a few weeks/months... Not mentioned the two new revolutional drugs huge potential within several months!

[Value_Investor]

Read the very important conference call from the link below and the two critical New drugs seem very promising in the next few months (up to the first half of 2017)...

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11458969

[Value_Investor]

CBYL is the cheapest Nasdaq stock in terms of Zero-Debt and $1.37 BV & $1.40 CV! Easy triple from the new bottom to $1.38 while the most recent high was $1.43...

Only 13.16M shares Hyper Tiny float! 50.02% Giant Insiders Ownership!

[Toxic Avenger]

LOL, it was earlier today you called the $.52 a bottom.
Definitely not an easy 100% gain - unless they liquidate, which gets less likely every day.
Remember, once the merger takes place, all of CBYL is about 20% of the new company and the existing (private) shareholders have 80% - and I'm betting CBYL is contributing way more than 20% of the cash, if not all of it to the merged company.
Basically, we're selling our cash at a 60% discount. Not a bad deal.

[Value_Investor]

CBYL hit another New bottom support $0.495 today! It will be bottomed out on next Monday. Hyper Undervalued now! Hyper Oversold during the past few days! Easy quick 100% gain from here...

The 52-week high is $5.74 v.s. at the joke low $0.496 now! The Analyst's rating is "Strong Buy"! Zero-Debt Bio-tech Nasdaq hidden gem! The Cash Value is $1.40! The $1.37 Book Value over the price is the highest among all the same industry peers! Only 26.32M shares Tiny OS and 13.16M shares Tiny float!

[Toxic Avenger]

Broke below $.5 now. That proxy appears to be causing a complete collapse. Maybe the newest investors thought there was a better chance of liquidating.

[Toxic Avenger]

Once the merger goes through, it will be just like any other biotech with a modest amount of cash and an drug candidate in early stages.

Before CYBL's drug trials failed, it was at $9/share. It then fell to $2.50 before crashing to 50 cents when they announced the merger.

It is not the safest or surest investment on the Nasdaq by a long stretch.

[Value_Investor]

Yesterday's low $0.5101 seems the New bottom support and CBYL should bounce from here to test $0.65 again as soon as the coming Monday...

Well, that proxy is just the expected merger news which was already announced in June or more than two months ago! Nothing new from June! Why this kind of the Repeated Same "news" would break down the previous strong support at $0.5302? Anyway $0.52 is the current daily low for today! Let's see if CBYL will test $0.5101 again today...

CBYL is the Cheapest and Ssafest Nasdaq stock in terms of extremely high Book Value and Cash Value plus Zero Debt among all the peers!

[Toxic Avenger]

They just sent out the proxy which again indicates most large holders support the merger. I imagine it panicked a number of retail holders.

[Value_Investor]

Disagreed! The next day CBYL actually bounced to $0.58 again and closed at $0.57! Not a "paint job" at all! Who would bid a stock to $0.58 with 10,000 shares while it closed at only $0.5398?

How about the big price decline in this morning --- CBYL sank to $0.5101?

Why the price of CBYL crashed so much --- from $0.6499 or $0.6497 just a day ago to today's low $0.5101 with the expected merger news (it was already announced in June) which is more than two months old?

[Value_Investor]

CBYL is on fire today and it just hit $0.6499 or $0.6497 so far! CBYL was also on fire yesterday (up to $0.58) as I predicted last Friday! $0.5302 is the New bottom support though the 52-week low was $0.485...

[Toxic Avenger]

Yeah, it was a paint at the end of the day. Typical of many stocks heading into a weekend. It will be back down on Monday.

The stock is undervalued based on liquidation, but for whatever reason, the company decided to throw it's large cash reserve into acquiring another bio tech which needs cash. And all they get is 20% of the company for that cash. That values KalVista at about $175 million, which clearly the market thinks is too high.
Based on CBYL's current price, the market values KalVista at about $70 million.

Definitely not zero risk as KalVista is just starting its phase 1 clinical trials on their one drug and results won't be announced until Q2 2017.

[Value_Investor]

4,800 shares Slapped at 0.58 ~ 0.5488 and also 5,200 shares left at the bid 0.58 but no any fill since the ask was 0.60! CBYL was up 7.45% ~ 1.67% in the AH of yesterday (last Friday)!

Hyper Undervalued now --- the BV is 2.54 Times of the current price and the CV is 2.6 Times of its joke low price!

Hyper Oversold now --- the price dropped from $1.43 just two months ago!

CBYL is the best Debt-Free Bio-Tech Nasdaq stock in terms of Extremely High Valuation and Zero Risk! Easy Triple from here...

[Toxic Avenger]

The $.58 was on 2 trades of 400 shares each.
The other 467,000 shares traded far below that price.

Maybe if the cancel the merger it will go up, but at this point, there doesn't seem to be much interest on the part of the company to do so.

[Value_Investor]

Wow, CBYL hit the New daily high $0.58 today in AH! The bid x ask was 5200-0.58 x 1000-0.60! It seems some very good news will kick in as soon as next Monday...

Anyway it is Hyper Oversold today & yesterday! Hyper Undervalued now!

CBYL is the cheapest Nasdaq Bio-tech hidden gem in terms of Zero Debt and Huge BV ($1.37) & CV ($1.4)!

[Value_Investor]

CBYL crashed to $0.5503 today from yesterday's high $0.65! The price further closed down to $0.5603 in the AH! It seems we should see the New 52-week low $0.49 testing again as soon as next week... Glad to have sold out all my shares at $0.6xxx! Today I just bought some cheap 0.55xx ~ 0.56xx shares and I'll load more dirt cheap shares at the bottom area $0.49 ~ $0.5502!

This stock is Hyper Manipulated by those very sick MMs and it seems impossible to hit $1.43 again though the CV is $1.40 and BV is $1.37...

[chrislal]

Ref: Value_Investor

Post # 305

I have no clue about charts but CBYL is definitely undervalue to me. You are the chartist and you definitely know that it has potential of going higher.

[Toxic Avenger]

Still trying to figure out why they would merge.

Terminating the deal costs them $4 million of their $37 million in cash. Subtracting all their liabilities of $2 million leaves them with $31 million cash, or $1.18 in cash - double the current stock price.

[Value_Investor]

Yes. CBYL hit $0.65 so far! It was $1.43 just two months ago... The Cash Value is $1.40 per share! The Book Value is $1.37 per share! It is a Debt-Free Bio-Tech Nasdaq hidden gem! CBYL is the cheapest Nasdaq stock in terms of BV, CV, and Zero Debt!

The 50-day MAL $0.68 will be tested again tomorrow...

[chrislal]

CBYL going to fly.

[Value_Investor]

Paying-off over $4M debts is a great news for all the shareholders! Now CBYL is a Debt-Free Bio-Tech Nasdaq stock with the highest BV (book value) over PPS (price per share) ratio and the highest CV (cash value) over PPS ratio! Of course if the company could cancel that "bad" deal then it would be another great news! But the issue is: canceling-that-deal will cost the company up to $4M cash --- in another word both the BV and CV will be reduced by $0.15 a share...

[Toxic Avenger]

It would be great if they hadn't agreed to merge with another money losing biotech.

[Value_Investor]

Great news for CBYL --- the 10-Q just came out in the AH on Friday!

Zero Debt!

Huge Book Value --- $1.37 per share!

Huge Cash Value --- $1.40 per share!

CBYL is the most valuable Nasdaq stock in terms of Debt, BV, and CV!

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11543612

[Value_Investor]

CBYL is the cheapest Nasdaq stock among Thousands of peers in terms of Huge Book Value, Huge Cash value, and No any debt at all!

[SsbTwentyTwo]

CBYL Chart

[Value_Investor]

Is it possible for the company to cancel that "bad" deal (see the link below) to liquidate the company in the near future? If the answer is "Yes" then CBYL will easily surge back to the most recent high $1.43 again since nothing has changed up to this moment!

The Book Value is $1.64 per share! The Cash Value is $1.84 per share!

http://www.sec.gov/Archives/edgar/data/1348911/000119312516621891/d176310dex21.htm

[Value_Investor]

Glad to see CBYL hit another new low $0.5601 today! I wish it test the All-Time-Low $0.52 again in the coming week...

[Value_Investor]

CBYL hit another New low $0.5701 today! So far 60.133% Huge price deline from the most recent high $1.43 just a few weeks ago!

[Value_Investor]

Very true. When will the company file the next financial report? TIA!

[Value_Investor]

$0.5712 seems the New bottom support besides the Real Bottom $0.52...

[Value_Investor]

It seems nothing to do with that R/S plan! Obviously all the shareholders do not like the proposed merger deal which drove the price down to $0.5712 from $1.43...

[Value_Investor]

Today CBYL hit $0.5712 again! I wish it tests the 52-week low $0.52 as soon as this week...

[Toxic Avenger]

No, the reverse split so they could uplist was announced long before the price drop. It started as soon as the acquisition was announced.

[bigbux1]

I suspect its because the planed Toxic R/S will kick in any day now!

[Toxic Avenger]

I'm not a biotech expert, but it seems to me the market is saying they don't, otherwise the price wouldn't be below their cash by so much.

[Value_Investor]

Unless the New drug from that private company has great perspectives!

[Toxic Avenger]

I agree. I'm holding shares just for that hope. I don't understand why the large shareholders or insiders (who are losing their jobs) agreed to this merger.

[Value_Investor]

What is the good part of that merger deal? I wish the company cancel that deal so that CBYL could bounce back to $1.43 or higher again...

[Toxic Avenger]

They are buying another company instead of liquidating and apparently the market consensus is, it's a really bad deal for them.

[Value_Investor]

Do you know why CBYL crashed to $0.5712 from $1.43 just a few weeks ago? There is nothing changed to the company balance sheet (BV & CV)!

[Value_Investor]

Quick question for all: when will the company make the next financial report? That should help us identify the Real value of CBYL!

[Value_Investor]

CBYL just hit $0.5712 one day ago! Hope to see the All-Time-Low $0.52 testing again in the coming week...

[Value_Investor]

CBYL hit $0.65 today! When will the company implement its R/S plan? TIA!

[Value_Investor]

If it is possible for the company to cancel this "bad" deal to liquidate the company in the near future? If the answer is "Yes" then CBYL will test $1.43 again since nothing has changed!

http://www.sec.gov/Archives/edgar/data/1348911/000119312516621891/d176310dex21.htm

[Value_Investor]

Excellent points! If the company liquidated itself then all the common shareholders will be paid about $1.5 per share which is way higher than today's high $0.6202! Why did they bother to merger CBYL with a worthless new company to damdage the shareholder's Equity?